Transcat, Inc. (TRNS)
NASDAQIndustrialsSpecialty Business ServicesSnapshot 2026-09-04
$85.48-0.26%
Close 2026-09-04 · 1-day change
NASDAQIndustrialsSpecialty Business ServicesSnapshot 2026-09-04
Intact: The reason to own it still holds.
Transcat targets high single-digit service revenue growth for fiscal 2027. Revenue grew from $67.7M in 2025-Q1 to $89.3M in 2026-Q4. The new CEO and recent M&A activity support strategic growth. Profitability remains stable with a robust quality profile.
Recent earnings misses and revenue shortfalls challenge growth targets. Management transitions have been volatile. The stock trades at a high PE of 47.2, above peers, risking valuation pressure.
The price is about 35% above our fair value near $65. Analysts expect about 9% revenue growth, which is roughly in line with management's high single-digit growth target. Our view is cautious given recent guidance cuts and earnings misses.
Breaks if: CEO transition leads to strategic setbacks or increased volatility
Breaks if: Failure to complete or integrate material M&A deals by FY27
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a durable compounder with a focus on organic growth and margin expansion. The current thesis state is intact, supported by strong recent financial performance, but it is also facing challenges from sector dynamics.
The valuation of TRNS is considered expensive compared to its peers, with a durable premium of 1.8. The market appears to have high expectations, as indicated by a 0.14 expectations gap, suggesting that any negative news could impact sentiment.
Management has demonstrated robust earnings quality and is on track with its priorities, including organic revenue growth and margin expansion. However, there is an elevated near-term risk of missing earnings estimates, particularly given the company's smaller size and erratic earnings history.
The long-term thesis hinges on the performance of sector bellwethers like CTAS, CPRT, and ROL. If these companies continue to perform well, it could support TRNS, but any negative guidance from them could create headwinds.
The most important moves since the prior daily snapshot.
Yes, our read has strengthened. The latest earnings beat supports this improved outlook. There are no new threats identified that would weaken the thesis.
as of 2026-09-04
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Breaks if: service organic revenue growth falls below 5% in FY27
Overall, TRNS is positioned well but must navigate sector challenges and maintain execution on its growth priorities. Not investment advice.